UroLift is a minimally invasive treatment option for benign prostatic hyperplasia (BPH), also called enlarged prostate. Medicare covers the UroLift procedure when a doctor deems it medically necessary ...

The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.

More than 50% of men over the age of 50 suffer from benign prostatic hyperplasia, also known as an enlarged prostate. While BPH is common for older men, causing the frequent urge to urinate — ...

Dr. Irina Jaeger, director of urology at University Hospitals Richmond Medical Center, is making UroLift treatment for benign prostatic hypertrophy, or BPH, available in the area for the first time.

A consultant urological, laparoscopic, and robotic surgeon, Professor Kingsley Ekwueme, has successfully performed West Africa's first UroLift procedure, a new minimally invasive treatment for ...